{
    "complex": false,
    "leverage": false,
    "derivatives": true,
    "swaps": false,
    "inverse": false,
    "replication_method": "physical",
    "ucits": true,
    "type": "ETF",
    "complex_factors": [
        "None identified"
    ],
    "classification": "non-complex",
    "supporting_data": "The UBS Factor MSCI USA Prime Value Screened UCITS ETF is classified as non-complex under MiFID II regulations. The primary replication method is physical, as confirmed in the factsheet ('Replication methodology: Physical (Full replicated)'). While the KIID mentions potential use of derivatives for index replication where direct investment is impractical, this appears to be for efficient portfolio management rather than as a core strategy. The fund does not employ leverage, inverse strategies, or synthetic replication. The underlying index (MSCI USA Prime Value Advanced Target Select Index) is a standard equity index with ESG screening, which does not introduce complexity. The risk profile (category 6) is high due to equity market volatility but does not stem from structural complexity. The fund is UCITS-compliant, further supporting its non-complex classification.",
    "confidence": 90,
    "counter_argument": "The KIID mentions derivative usage, which could suggest complexity. However, the factsheet clarifies this is for physical replication purposes only, and the derivatives are not used for leverage or speculative purposes. The fund's transparency, liquidity, and straightforward index-tracking objective outweigh this factor.",
    "risk_level": 6,
    "esg_considerations": "The fund incorporates ESG screening but this does not contribute to complexity under MiFID II. The ESG factors are clearly disclosed and do not alter the fundamental investment strategy."
}